NO20032371L - Makrolidsolvater - Google Patents

Makrolidsolvater

Info

Publication number
NO20032371L
NO20032371L NO20032371A NO20032371A NO20032371L NO 20032371 L NO20032371 L NO 20032371L NO 20032371 A NO20032371 A NO 20032371A NO 20032371 A NO20032371 A NO 20032371A NO 20032371 L NO20032371 L NO 20032371L
Authority
NO
Norway
Prior art keywords
makrolidsolvater
azithromycin
monohydrate
preparation
water
Prior art date
Application number
NO20032371A
Other languages
English (en)
Other versions
NO324951B1 (no
NO20032371D0 (no
Inventor
Victor Centellas
Jose Diago
Rafael Garcia
Johannes Ludescher
Original Assignee
Biochemie Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0031355A external-priority patent/GB0031355D0/en
Application filed by Biochemie Sa filed Critical Biochemie Sa
Publication of NO20032371D0 publication Critical patent/NO20032371D0/no
Publication of NO20032371L publication Critical patent/NO20032371L/no
Publication of NO324951B1 publication Critical patent/NO324951B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Azitromycin i form av et monohydrat som innbefatter fra 4,0% til 6,5% vann, en fremgangsmåte for dets fremstilling og dets anvendelse i farmasøytiske sammensetninger.
NO20032371A 2000-11-27 2003-05-26 Azitromycin og fremgangsmate for fremstilling derav NO324951B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25311900P 2000-11-27 2000-11-27
GB0031355A GB0031355D0 (en) 2000-12-21 2000-12-21 Organic compounds
PCT/EP2001/013760 WO2002042315A2 (en) 2000-11-27 2001-11-26 Macrolide solvates

Publications (3)

Publication Number Publication Date
NO20032371D0 NO20032371D0 (no) 2003-05-26
NO20032371L true NO20032371L (no) 2003-07-10
NO324951B1 NO324951B1 (no) 2008-01-14

Family

ID=26245472

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032371A NO324951B1 (no) 2000-11-27 2003-05-26 Azitromycin og fremgangsmate for fremstilling derav

Country Status (15)

Country Link
US (1) US6949519B2 (no)
EP (1) EP1339730A2 (no)
JP (1) JP2004519430A (no)
KR (1) KR100815163B1 (no)
AU (1) AU2002221895A1 (no)
BG (1) BG66200B1 (no)
CA (1) CA2429639C (no)
CZ (1) CZ303343B6 (no)
EE (1) EE05200B1 (no)
HR (1) HRP20030430B1 (no)
HU (1) HU229488B1 (no)
NO (1) NO324951B1 (no)
PL (1) PL207076B1 (no)
SK (1) SK287814B6 (no)
WO (1) WO2002042315A2 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
DE60209704T2 (de) 2001-05-22 2006-11-16 Pfizer Products Inc., Groton Neue kristallforme von azithromycin
GB0214277D0 (en) * 2002-06-20 2002-07-31 Biochemie Gmbh Organic compounds
US6855813B2 (en) 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB0224197D0 (en) * 2002-10-17 2002-11-27 Biochemie Gmbh Organic compounds
EP1606299A1 (en) * 2003-03-25 2005-12-21 Teva Pharmaceutical Industries Ltd. Degradation products of azithromycin, and methods for their identification
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
JP4471941B2 (ja) * 2005-03-10 2010-06-02 山一電機株式会社 半導体装置用ソケット
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
CN102413826A (zh) 2009-03-13 2012-04-11 达·沃尔泰拉公司 用于消除革兰氏阴性菌的组合物和方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
PT102006B (pt) 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
PT102130A (pt) * 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
US6245903B1 (en) * 1998-08-21 2001-06-12 Apotex, Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
US6365574B2 (en) * 1998-11-30 2002-04-02 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
US6703372B1 (en) * 1999-06-29 2004-03-09 Biochemie S.A. Macrolides
ES2177373B1 (es) 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina

Also Published As

Publication number Publication date
HU229488B1 (hu) 2014-01-28
EP1339730A2 (en) 2003-09-03
CZ20031439A3 (cs) 2003-10-15
WO2002042315A2 (en) 2002-05-30
CZ303343B6 (cs) 2012-08-08
US6949519B2 (en) 2005-09-27
HRP20030430B1 (hr) 2011-11-30
AU2002221895A1 (en) 2002-06-03
CA2429639C (en) 2009-07-14
PL361276A1 (en) 2004-10-04
HUP0302099A2 (hu) 2003-10-28
NO324951B1 (no) 2008-01-14
US20040053862A1 (en) 2004-03-18
HRP20030430A2 (en) 2005-04-30
HUP0302099A3 (en) 2009-08-28
PL207076B1 (pl) 2010-10-29
CA2429639A1 (en) 2002-05-30
EE05200B1 (et) 2009-08-17
SK287814B6 (sk) 2011-11-04
EE200300255A (et) 2003-08-15
BG66200B1 (bg) 2012-01-31
JP2004519430A (ja) 2004-07-02
KR20030055305A (ko) 2003-07-02
KR100815163B1 (ko) 2008-03-19
BG107832A (bg) 2004-07-30
SK6352003A3 (en) 2003-11-04
WO2002042315A3 (en) 2002-10-31
NO20032371D0 (no) 2003-05-26

Similar Documents

Publication Publication Date Title
HUP0301742A3 (en) Colchinol derivatives as angiogenesis inhibitors, process for producing them, pharmaceutical compositions containing them and their use
HUP0302257A3 (en) 4-hydrazino-5-hydroxy-5-pyrazol derivatives, pharmaceutical compositions containing them, process for producing them and their intermediates
HUP0302230A3 (en) Polyarylcarboxamides useful as lipid lowering agents, process for producing them and pharmaceutical compositions containing them
DK1202733T3 (da) 3(5)-amino-pyrazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som antitumormidler
NL350075I2 (no)
DE60236102D1 (en) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
HUP0400781A3 (en) Process for the crystallization of (r)- or (s)-lansoprazole, the prepared crystalls and pharmaceutical compositions containing them and their use
ES2189768T3 (es) Sintesis regioselectiva de derivados de rapamicina.
HUP0301069A3 (en) Novel biarylcarboxamides, process for their preparation, pharmaceutical compositions containing them and their use
TW200510375A (en) New compounds
HUP0301651A2 (en) Indolylmaleimide derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP0102723A3 (en) New diphenylurea derivatives, process for their preparation and pharmaceutical compositions containing them
CA2400268A1 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
HUP0303109A3 (en) Indolin-2-one derivatives, process for producing them and pharmaceutical compositions containing them
HUP0302226A3 (en) Substituted pyrrolopyridinone dervatives useful as phosphodiesterse inhibitors, their intermediates and pharmaceutical compositions containing the compounds
ATE302786T1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
NO20031622L (no) Medisinske blandinger som raskt desintegrerer i munnhulen og fremgangsmåtefor fremstilling av samme
HUP0303006A3 (en) Retinoids for the treatment of emphysema, process for their preparation and pharmaceutical compositions containing them
CA2429639A1 (en) Stable azithromycin monohydrate
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
HUP0301075A3 (en) Diphenyl ether derivatives, their use for preparation of pharmaceutical compositions and process for preparation the compounds
DK0579681T3 (da) Krystallinsk tiagabin-hydrochlorid-monohydrat, dets fremstilling og dets anvendelse
HUP0500137A2 (en) Pyrrolidine-2-ones as factor xa inhibitors, process for producing them and pharmaceutical compositions containing the same
DE60121804D1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
DK1122254T3 (da) 4-sulfonamidpiperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees